Search Results
Sep 17, 2025, 03:40 ET Alteogen Receives European Commission Approval for Aflibercept Biosimilar, EYLUXVI® (ALT-L9)
Sept. 17, 2025 /PRNewswire/ -- Alteogen Inc. (KOSDAQ:196170) announced today that the European Commission (EC) has granted marketing authorization for EYLUXVI® (code name: ALT-L9), an Eylea® biosimilar co-developed by its subsidiary,
More news about: Alteogen Inc.
Sep 16, 2025, 09:00 ET CDW & AMD Collaborate to Enable Mission to Maximize AWS Cloud Efficiency
enterprises to optimize cloud spending, streamline migrations, and achieve sustainability goals with AMD EPYC CPU-powered Amazon Elastic Compute Cloud (Amazon EC2) instances. VERNON HILLS, Ill.,
More news about: Mission
Sep 15, 2025, 08:30 ET Innovative Therapeutics Pipeline Positions Industry for Strong Market Growth
announced that the European Commission (EC) has granted marketing authorization for AUCATZYL(R) (obecabtagene autoleucel or "obe-cel") for the treatment of adult patients, 26-plus, with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (r/r B-ALL). The EC approval was based on the results
More news about: NetworkNewsWire
Sep 15, 2025, 08:19 ET UPM Adhesive Materials showcases its solutions for leading label material performance at Labelexpo Europe 2025
https://news.cision.com/upm-kymmene-oyj/r/upm-adhesive-materials-showcases-its-solutions-for-leading-label-material-performance-at-labelexpo-e,c4233597 The following files are available for download:
More news about: UPM-Kymmene Oyj